Stock listing
A2PKLC Stock Price, News, Filings & Events — Armata Pharmaceuticals, Inc.
Selected listing: A2PKLC · LSX · EUR · DE
This page tracks Armata Pharmaceuticals, Inc.'s A2PKLC:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2PKLC:LSX. A2PKLC:LSX is the stock-level entry point for investors researching Armata Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Armata Pharmaceuticals, Inc. (ticker: ARMP) is a public company based in the United States, focusing on innovative therapies for bacterial infections. With a market capitalization of approximately $165.6 million, Armata is dedicated to advancing its pipeline of treatments aimed at addressing unmet medical needs in infectious diseases. The company is committed to developing solutions that improve patient outcomes and...
- Ticker
- A2PKLC:LSX
- Asset type
- Stock
- Market cap
- $200.0M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- LSX
- Currency
- EUR
Armata Pharmaceuticals, Inc. A2PKLC:LSX stock context
This page tracks Armata Pharmaceuticals, Inc.'s A2PKLC:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2PKLC:LSX. A2PKLC:LSX is the stock-level entry point for investors researching Armata Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Armata Pharmaceuticals, Inc. (ticker: ARMP) is a public company based in the United States, focusing on innovative therapies for bacterial infections. With a market capitalization of approximately $165.6 million, Armata is dedicated to advancing its pipeline of treatments aimed at addressing unmet medical needs in infectious diseases. The company is committed to developing solutions that improve patient outcomes and...
Latest news from Armata Pharmaceuticals, Inc.
Armata Pharmaceuticals Announces Financial Results for the Second Quarter 2026 and Provides a Corporate Update
August 12, 2026
Armata Pharmaceuticals Receives Agreement from FDA on Initial Pediatric Study Plan for AP-SA02 for the Treatment of Complicated Staphyloc...
July 13, 2026
Armata Pharmaceuticals Receives $2.5 Million of Additional Non-Dilutive Award Funding from the U.S. Department of Defense to Support AP-SA02
June 23, 2026
Armata Pharmaceuticals Announces First Quarter 2026 Results and Provides Corporate Update
May 13, 2026
Armata Pharmaceuticals Secures FDA Fast Track Designation for AP-SA02
May 7, 2026
Research Armata Pharmaceuticals, Inc.
Armata Pharmaceuticals, Inc. investor report
Review AI stock analysis and investor report context for A2PKLC:LSX.
Armata Pharmaceuticals, Inc. company profile
View the public company page for Armata Pharmaceuticals, Inc. on 6ix.
Armata Pharmaceuticals, Inc. news
Read company news and market updates connected to Armata Pharmaceuticals, Inc..
Armata Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Armata Pharmaceuticals, Inc..
Alternate listings
ARMP:AMEX
US · USD
Alternate listing for Armata Pharmaceuticals, Inc.; the primary context on this page is A2PKLC:LSX.
TG1N:GETTEX
DE · EUR
Alternate listing for Armata Pharmaceuticals, Inc.; the primary context on this page is A2PKLC:LSX.
A2PKLC:LS
DE · EUR
Alternate listing for Armata Pharmaceuticals, Inc.; the primary context on this page is A2PKLC:LSX.
ARMP:BOATS
US · USD
Alternate listing for Armata Pharmaceuticals, Inc.; the primary context on this page is A2PKLC:LSX.
TG1N:TRADEGATE
DE · EUR
Alternate listing for Armata Pharmaceuticals, Inc.; the primary context on this page is A2PKLC:LSX.
TG1N:DUS
DE · EUR
Alternate listing for Armata Pharmaceuticals, Inc.; the primary context on this page is A2PKLC:LSX.
TG1N:FWB
DE · EUR
Alternate listing for Armata Pharmaceuticals, Inc.; the primary context on this page is A2PKLC:LSX.
TG1N:MUN
DE · EUR
Alternate listing for Armata Pharmaceuticals, Inc.; the primary context on this page is A2PKLC:LSX.
TG1N:SWB
DE · EUR
Alternate listing for Armata Pharmaceuticals, Inc.; the primary context on this page is A2PKLC:LSX.